Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852227 · ClinicalTrials.gov registry record
ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 500
- Enrollment target
NCT01852227: Completed study, sponsored by Medical University of South Carolina.
NCT01852227 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01852227 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
In collaboration with the Neurointerventional programs at state university of new york Buffalo, state university of new york Stonybrook, Swedish Medical Center, Erlanger Health System, Vanderbilt University, and West Virginia University School of Medicine, the investigators aim to prospectively collect experiences where direct aspiration as a first pass technique is used for thrombectomy procedures. The investigators also want to compare specific characteristics from these cases to other stroke cases where traditional thrombectomy devices were used.
Primary Outcome
a national institutes of health stroke scale (NIHSS) will be obtained at the time of the each patient's discharge or approximately 7 days
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-05 |
What the finished NCT01852227 record still lists
NCT01852227 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01852227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01852227 about?
NCT01852227 is a clinical study titled "ADAPT A Direct Aspiration, First Pass Technique for the Endovascular Treatment of Stroke". In collaboration with the Neurointerventional programs at state university of new york Buffalo, state university of new york Stonybrook, Swedish Medical Center, Erlanger Health System, Vanderbilt University, and West Virginia University School of Medicine, the investigators aim to prospectively coll...
What is the current status of trial NCT01852227?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2013-06. Estimated completion is 2016-05.
Who is sponsoring clinical trial NCT01852227?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia